Reduced incidence of hemophagocytic lymphohistiocytosis in Japan during the COVID-19 pandemic

Int J Hematol. 2022 Mar;115(3):446-448. doi: 10.1007/s12185-022-03302-2. Epub 2022 Feb 3.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • COVID-19*
  • Humans
  • Incidence
  • Japan / epidemiology
  • Lymphohistiocytosis, Hemophagocytic* / epidemiology
  • Lymphohistiocytosis, Hemophagocytic* / etiology
  • Pandemics
  • SARS-CoV-2